PharmaCyte Biotech, Inc. (PMCB) › Total LiabilitiesPharmaCyte Biotech, Inc. (PMCB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $3.39M2012: $3.79M2013: $3.80M2014: $373.7K2015: $1.52M2016: $637.6K2017: $580.2K2018: $644.2K2019: $742.9K2020: $1.08M2021: $724.8K2022: $704.4K2023: $586.6K2024: $20.39M2025: $3.28M$3.28M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$3.28M-83.9%2024$20.39M+3376.0%2023$586.6K-16.7%2022$704.4K-2.8%2021$724.8K-32.7%2020$1.08M+45.1%2019$742.9K+15.3%2018$644.2K+11.0%2017$580.2K-9.0%2016$637.6K-58.1%2015$1.52M+306.9%2014$373.7K-90.2%2013$3.80M+0.3%2012$3.79M+11.7%2011$3.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share